John V. Duncia - Hockessin DE Joseph B. Santella - Springfield PA Dean A. Wacker - Chadds Ford PA Wenqing Yao - Kennett Square PA Changsheng Zheng - Wilmington DE
Assignee:
Bristol-Myers Squibb Pharma Company - Princeton NJ
The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
N-Ureidoalkyl-Piperidines As Modulators Of Chemokine Receptor Activity
Soo S. Ko - Hockessin DE, US George V. Delucca - Wilmington DE, US John V. Duncia - Hockessin DE, US Ui Tae Kim - Wilmington DE, US Dean A. Wacker - Chadds Ford PA, US Changsheng Zheng - Wilmington DE, US
Assignee:
Bristol-Myers Squibb Pharma Company - Princeton NJ
The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
Piperidine Amides As Modulators Of Chemokine Receptor Activity
John V. Duncia - Hockessin DE, US Joseph B. Santella - Springfield PA, US Dean A. Wacker - Chadds Ford PA, US Wenqing Yao - Kennett Square PA, US Changsheng Zheng - Wilmington DE, US
Assignee:
Bristol-Myers Squibb Pharma, Company - Princeton NJ
The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
3-(4-Heteroarylcyclohexylamino)Cyclopentanecarboxamides As Modulators Of Chemokine Receptors
Changsheng Zheng - Wilmington DE, US Ganfeng Cao - Newark DE, US Hao Feng - Aston PA, US Michael Xia - Hockessin DE, US Rajan Anand - Wilmington DE, US Joseph Glenn - Sicklerville NJ, US Brian W. Metcalf - Moraga CA, US
Assignee:
Incyte Corporation - DE
International Classification:
C07D 471/02 A61K 31/47
US Classification:
514300, 514310, 546122, 546146
Abstract:
The present invention is directed to compounds of Formula I:.
3-Aminocyclopentanecarboxamides As Modulators Of Chemokine Receptors
Changsheng Zheng - Wilmington DE, US Hao Feng - Aston PA, US Michael Xia - Hockessin DE, US Joseph Glenn - Sicklerville NJ, US Ganfeng Cao - Newark DE, US Brian W. Metcalf - Moraga CA, US
Brian Metcalf - Moraga CA, US Anlai Wang - Wilmington DE, US Changsheng Zheng - Wilmington DE, US Ganfeng Cao - Bear DE, US Ke Zhang - Wilmington DE, US
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.
Changsheng Zheng - Wilmington DE, US Ganfeng Cao - Bear DE, US Michael Xia - Wilmington DE, US Anlai Wang - Wilmington DE, US Hai Fen Ye - Newark DE, US Brian Metcalf - Moraga CA, US
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.
3-Cycloalkylaminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
Brian W. Metcalf - Moraga CA, US Amy Qi Han - Hockessin DE, US Darius J. Robinson - Wilmington DE, US Changsheng Zheng - Wilmington DE, US Anlai Wang - Wilmington DE, US Yingxin Zhang - New Castle DE, US
International Classification:
C07D 403/14 A61K 31/506
US Classification:
514256, 544333
Abstract:
The present invention relates to 3-cycloalkylaminopyrrolidine derivatives of the formula I:.